GeneDx Holdings Corp vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? GeneDx Holdings Corp trades at $61.92 (market cap $1.80B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.7. The key difference: Roundhill S&P 500 0DTE Covered Call Strategy ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| WGS | XDTE | |
|---|---|---|
Market Cap | $1.80B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $167.51 | $44.76 |
52-Week Low | $34.51 | $36.00 |
Enterprise Value | $1.80B | — |
Trailing returns across standard periods
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →